Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.
Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, Gutzmer R, Utikal JS, Goldinger SM, Geier M, Hassel JC, Balermpas P, Kiecker F, Rauschenberg R, Dietrich U, Clemens P, Berking C, Grabenbauer G, Schadendorf D, Grabbe S, Schuler G, Fietkau R, Distel LV, Heinzerling L. Hecht M, et al. Among authors: forschner a. Br J Cancer. 2018 Mar 20;118(6):785-792. doi: 10.1038/bjc.2017.489. Epub 2018 Feb 13. Br J Cancer. 2018. PMID: 29438368 Free PMC article.
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study.
L'Orphelin JM, Cassecuel J, Kandolf L, Harwood CA, Tookey P, Junejo MH, Hogan S, Lebbé C, Appalla Z, Kränke TM, Pellacani G, Cerasuolo D, Dujovic B, Del Marmol V, Forschner A, Garbe C, Bataille V, Ressler JM, Sollena P, Dompmartin A, Peris K, Dreno B; And European Association of Dermato-Oncology. L'Orphelin JM, et al. Among authors: forschner a. J Eur Acad Dermatol Venereol. 2023 Apr 12. doi: 10.1111/jdv.19112. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 37042810
UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescents.
Liebmann A, Admard J, Armeanu-Ebinger S, Wild H, Abele M, Gschwind A, Seibel-Kelemen O, Seitz C, Bonzheim I, Riess O, Demidov G, Sturm M, Schadeck M, Pogoda M, Bien E, Krawczyk M, Jüttner E, Mentzel T, Cesen M, Pfaff E, Kunc M, Forchhammer S, Forschner A, Leiter-Stöppke U, Eigentler TK, Schneider DT, Schroeder C, Ossowski S, Brecht IB. Liebmann A, et al. Among authors: forschner a. EBioMedicine. 2023 Oct;96:104797. doi: 10.1016/j.ebiom.2023.104797. Epub 2023 Sep 14. EBioMedicine. 2023. PMID: 37716236 Free PMC article.
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study.
Reinert CP, Liang C, Weissinger M, Vogel J, Forschner A, Nikolaou K, la Fougère C, Seith F. Reinert CP, et al. Among authors: forschner a. Diagnostics (Basel). 2023 Jun 5;13(11):1963. doi: 10.3390/diagnostics13111963. Diagnostics (Basel). 2023. PMID: 37296815 Free PMC article.
Melanoma staging: facts and controversies.
Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C. Forschner A, et al. Clin Dermatol. 2010 May-Jun;28(3):275-80. doi: 10.1016/j.clindermatol.2009.06.012. Clin Dermatol. 2010. PMID: 20541679
Incisional biopsy and melanoma prognosis: Facts and controversies.
Pflugfelder A, Weide B, Eigentler TK, Forschner A, Leiter U, Held L, Meier F, Garbe C. Pflugfelder A, et al. Among authors: forschner a. Clin Dermatol. 2010 May-Jun;28(3):316-8. doi: 10.1016/j.clindermatol.2009.06.013. Clin Dermatol. 2010. PMID: 20541685 Review.
140 results